Compare CEPL & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CEPL | RPID |
|---|---|---|
| Founded | 1988 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.5M | 84.8M |
| IPO Year | 2000 | 2021 |
| Metric | CEPL | RPID |
|---|---|---|
| Price | $2.79 | $0.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $16.50 | $5.75 |
| AVG Volume (30 Days) | ★ 374.7K | 184.6K |
| Earning Date | 11-12-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2.78 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $106,004,000.00 | $33,587,000.00 |
| Revenue This Year | $2.85 | $16.95 |
| Revenue Next Year | $32.04 | $17.92 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 23.89 | 19.74 |
| 52 Week Low | $2.55 | $0.76 |
| 52 Week High | $12.32 | $4.94 |
| Indicator | CEPL | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 32.42 | 29.67 |
| Support Level | N/A | $0.76 |
| Resistance Level | $6.85 | $2.18 |
| Average True Range (ATR) | 0.35 | 0.05 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 13.62 | 18.00 |
Capstone Energy+ Inc provides behind-the-meter clean energy solutions for industrial and commercial operations, as well as solutions for artificial intelligence (AI) and data center applications. It develops and manufactures oil-free, microturbine-based power generation systems designed to operate on a range of gaseous fuels.
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.